Clinical Trials · NCT05574712
A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Enrollment
- 0
- Start date
- Jan 2024
- Locations
- See registry
- Primary endpoint
- Rate of near pathological complete response (pCR)